Original BioMedicals Co., Ltd. (TPEX:6483)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
15.05
-0.10 (-0.66%)
Apr 29, 2026, 1:57 PM CST
Market Cap1.01B +3.8%
Revenue (ttm)381.00K
Net Income-101.51M
EPS-1.53
Shares Out66.59M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume38,010
Average Volume256,975
Open15.10
Previous Close15.15
Day's Range14.95 - 15.15
52-Week Range9.12 - 20.00
Beta0.34
RSI45.29
Earnings DateAug 10, 2026

About Original BioMedicals

Original BioMedicals Co., Ltd., engages in the development of new drugs with non-new ingredients in Taiwan. It develops OBM-A01, for the treatment of acute radiation injury, including nuclear radiation and solar radiation exposed in space; OBM-B01, a cyanide compound drug for protection against toxic gases from fires; and CCM-CL, a cyclic polypeptide antibiotic. The company was founded in 2011 and is based in Tainan City, Taiwan. [Read more]

Sector Healthcare
Founded 2011
Employees 23
Stock Exchange Taipei Exchange
Ticker Symbol 6483
Full Company Profile

Financial Performance

Financial Statements